The evolution of non-diabetic hyperglycemia: A longitudinal study

Endocrine Journal

Volumn 61, Issue 1, 2014, Pages 91-99

  Oka, Rie ^a   Yagi, Kunimasa ^b   Hayashi, Kenshi ^b   Kawashiri, Masa Aki ^b   Yamagishi, Masakazu ^b   Yamada, Masayuki ^c   Fumisawa, Yasushi ^d   Yamauchi, Keishi ^d   Aizawa, Toru ^d  

^a Hokuriku Central Hospital   (Japan)

^b KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^c Clinical Research Department Kissei Pharmaceutical   (Japan)

^d Aizawa Hospital   (Japan)

Author keywords

Impaired fasting glucose; Impaired glucose tolerance; Normal glucose tolerance; OGTT

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; ATTENUATION; BODY MASS; DISEASE PREDISPOSITION; FAMILY HISTORY; FEMALE; FOLLOW UP; GLUCOSE STIMULATED INSULIN SECRETION; GLUCOSE TOLERANCE; HUMAN; HYPERGLYCEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RELEASE; INSULIN SENSITIVITY; JAPANESE; LOGISTIC REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET BETA CELL; RETROSPECTIVE STUDY; RISK FACTOR; SEX DIFFERENCE;

BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS; FASTING; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; HYPERGLYCEMIA; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; JAPAN; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PREDIABETIC STATE; RETROSPECTIVE STUDIES; RISK FACTORS; SEX FACTORS;

EID: 84893350491     PISSN: 09188959     EISSN: 13484540     Source Type: Journal    
DOI: 10.1507/endocrj.EJ13-0359     Document Type: Article

References (34)

1. Tataranni PA, Bogardus C (2004) Metabolic abnormalities in the development of type 2 diabetes mellitus. In: LeRoith D, Olefsky JM, Taylor SI (eds) Diabetes Mellitus: A Fundamental and Clinical Text (3rd ed). Lippincott Williams & Wilkins, Philadelphia: 797-807.
2. Alsahli M, Gerich JE (2010) Abnormalities of insulin secretion and β-cell defects in type 2 diabetes. In: Holt RIG, Cockram C, Flyvbjerg A, Goldstein BJ (eds) Textbook of Diabetes (4th ed). Wiley-Blackwell, Chichester: 160-173.
3. Lillioja S, Mott DM, Howard BV, Bennett PH, Yki-Järvinen H, et al. (1988) Impaired glucose tolerance as a disorder of insulin action. Longitudinal and cross-sectional studies in Pima Indians. N Engl J Med 318: 1217-1225.
4. Warram JH, Sigal RJ, Martin BC, Krolewski AS, Soeldner JS (1996) Natural history of impaired glucose tolerance: follow-up at Joslin Clinic. Diabet Med 13(9 Suppl 6): S40-45.
5. Weyer C, Tataranni PA, Bogardus C, Pratley RE (2001) Insulin resistance and insulin secretory dysfunction are independent predictors of worsening of glucose tolerance during each stage of type 2 diabetes development. Diabetes Care 24: 89-94.
6. Goldfine AB, Bouche C, Parker RA, Kim C, Kerivan A, et al. (2003) Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A 100: 2724-2729.
7. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, et al. (2009) Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study. Lancet 373: 2215-2221.
8. Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, et al. (2009) Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study. Diabetes Care 32: 439-444.
9. Ferrannini E, Natali A, Muscelli E, Nilsson PM, Golay A, et al.; RISC Investigators (2011) Natural history and physiological determinants of changes in glucose tolerance in a non-diabetic population: the RISC Study. Diabetologia 54: 1507-1516.
10. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, et al. (1997) Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544.
11. Tuomilehto J, Lindström J, Eriksson JG, Valle TT, Hämäläinen H, et al.; Finnish Diabetes Prevention Study Group (2001) Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glu-cose tolerance. N Engl J Med 344: 1343-1350.
12. Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, et al.; Diabetes Prevention Program Research Group (2002) Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 346: 393-403.
13. No authors listed (2011) The diabetes pandemic. Lancet 378: 99.
14. Kahn SE, Leonetti DL, Prigeon RL, Boyko EJ, Bergstrom RW, et al. (1995) Proinsulin as a marker for the development of NIDDM in Japanese-American men. Diabetes 44: 173-179.
15. Nagi DK, Knowler WC, Mohamed-Ali V, Bennett PH, Yudkin JS (1998) Intact proinsulin, des 31,32 proinsulin, and specific insulin concentrations among nondiabetic and diabetic subjects in populations at varying risk of type 2 diabetes. Diabetes Care 21: 127-133.
16. Larsson H, Ahrén B (1999) Relative hyperproinsulinemia as a sign of islet dysfunction in women with impaired glucose tolerance. J Clin Endocrinol Metab 84: 2068-2074.
17. Grill V, Dinesen B, Carlsson S, Efendic S, Pedersen O, et al. (2002) Ostenson CG. Hyperproinsulinemia and proinsulin-to-insulin ratios in Swedish middle-aged men: association with glycemia and insulin resistance but not with family history of diabetes. Am J Epidemiol 155: 834-841.
18. Oka R, Yagi K, Sakurai M, Nakamura K, Moriuchi T, et al. (2012) Insulin secretion and insulin sensitivity on the oral glucose tolerance test (OGTT) in middle-aged Japanese. Endocr J 59: 55-64.
19. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, et al., The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Follow-up report on the diagnosis of diabetes mellitus (2003) Diabetes Care 26: 3160-3167.
20. Marcovina S, Bowsher RR, Miller WG, Staten M, Myers G, et al.; Insulin Standardization Workgroup (2007) Standardization of insulin immunoassays: report of the American Diabetes Association Workgroup. Clin Chem 53: 711-716.
21. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-1470.
22. DeFronzo RA, Matsuda M (2010) Reduced time points to calculate the composite index. Diabetes Care 33: e93.
23. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, et al. (2000) Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 85: 2402-2410.
24. Soonthornpun S, Setasuban W, Thamprasit A, Chayanunnukul W, Rattarasarn C, et al. (2003) Novel insulin sensitivity index derived from oral glucose tolerance test. J Clin Endocrinol Metab 88: 1019-1023.
25. Stumvoll M, Mitrakou A, Pimenta W, Jenssen T, Yki-Järvinen H, et al. (2000) Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity. Diabetes Care 23: 295-301.
26. https://www.dtu.ox.ac.uk/homacalculator/index.php
27. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, et al. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419.
28. Peduzzi P, Concato J, Kemper E, Holford TR, Feinstein AR (1996) A simulation study of the number of events per variable in logistic regression analysis. J Clin Epidemiol 49: 1373-1379.
29. World Health Organization: Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications. Report of a WHO Consultation. Part 1: Diagnosis and Classification of Diabetes Mellitus. Geneva, World Health Organization, 1999.
30. Nathan DM, Davidson MB, DeFronzo RA, Heine RJ, Henry RR, et al.; American Diabetes Association (2007) Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care 30: 753-759.
31. Abdul-Ghani MA, Abdul-Ghani T, Stern MP, Karavic J, Tuomi T, et al. (2011) Two-step approach for the prediction of future type 2 diabetes risk. Diabetes Care 34: 2108-2112.
32. Falster DS, Warton DI, Wright IJ. SMATR: standardized major axis tests and routines, ver 2.0. Available from, http://www.bio.mq.edu.au/ecology/SMATR/
33. Sokal RR, Rohlf FJ (2011) Biometry (4th ed). WH Freeman and Company, New York.
34. Warton DI, Wright IJ, Falster DS, Westoby M (2006) Bivariate line-fitting methods for allometry. Biol Rev Camb Philos Soc 81: 259-291.